CN105873634A - 透皮释放活性物质的系统 - Google Patents

透皮释放活性物质的系统 Download PDF

Info

Publication number
CN105873634A
CN105873634A CN201480070086.3A CN201480070086A CN105873634A CN 105873634 A CN105873634 A CN 105873634A CN 201480070086 A CN201480070086 A CN 201480070086A CN 105873634 A CN105873634 A CN 105873634A
Authority
CN
China
Prior art keywords
active substance
carrier material
tts
backing layer
hook
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201480070086.3A
Other languages
English (en)
Chinese (zh)
Inventor
M·萨梅蒂
R·哈克巴斯
K·舒曼
C·施密茨
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LTS Lohmann Therapie Systeme AG
Original Assignee
LTS Lohmann Therapie Systeme AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LTS Lohmann Therapie Systeme AG filed Critical LTS Lohmann Therapie Systeme AG
Priority to CN202011091427.9A priority Critical patent/CN112206223B/zh
Publication of CN105873634A publication Critical patent/CN105873634A/zh
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/02—Details
    • A61N1/04—Electrodes
    • A61N1/0404—Electrodes for external use
    • A61N1/0408—Use-related aspects
    • A61N1/0428—Specially adapted for iontophoresis, e.g. AC, DC or including drug reservoirs
    • A61N1/0448—Drug reservoir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00—Bandages or dressings; Absorbent pads
    • A61F13/02—Adhesive bandages or dressings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4468—Non condensed piperidines, e.g. piperocaine having a nitrogen directly attached in position 4, e.g. clebopride, fentanyl
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/2271—Neuropeptide Y
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/27—Growth hormone [GH], i.e. somatotropin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/36—Blood coagulation or fibrinolysis factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/02—Details
    • A61N1/04—Electrodes
    • A61N1/0404—Electrodes for external use
    • A61N1/0408—Use-related aspects
    • A61N1/0428—Specially adapted for iontophoresis, e.g. AC, DC or including drug reservoirs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/02—Details
    • A61N1/04—Electrodes
    • A61N1/0404—Electrodes for external use
    • A61N1/0408—Use-related aspects
    • A61N1/0428—Specially adapted for iontophoresis, e.g. AC, DC or including drug reservoirs
    • A61N1/0432—Anode and cathode
    • A61N1/0436—Material of the electrode
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/20—Applying electric currents by contact electrodes continuous direct currents
    • A61N1/30—Apparatus for iontophoresis, i.e. transfer of media in ionic state by an electromotoric force into the body, or cataphoresis
    • A61N1/303—Constructional details
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A61M2037/0007—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin having means for enhancing the permeation of substances through the epidermis, e.g. using suction or depression, electric or magnetic fields, sound waves or chemical agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2207/00—Methods of manufacture, assembly or production

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Radiology & Medical Imaging (AREA)
  • Endocrinology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Diabetes (AREA)
  • Dermatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Medical Informatics (AREA)
  • Anesthesiology (AREA)
  • Rheumatology (AREA)
  • Otolaryngology (AREA)
  • Hospice & Palliative Care (AREA)
  • Vascular Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CN201480070086.3A 2013-12-20 2014-12-17 透皮释放活性物质的系统 Pending CN105873634A (zh)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202011091427.9A CN112206223B (zh) 2013-12-20 2014-12-17 透皮释放活性物质的系统

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP13199189.5A EP2886153A1 (de) 2013-12-20 2013-12-20 System für die transdermale Abgabe von Wirkstoff
EP13199189.5 2013-12-20
PCT/EP2014/003399 WO2015090583A1 (de) 2013-12-20 2014-12-17 System für die transdermale abgabe von wirkstoff

Related Child Applications (1)

Application Number Title Priority Date Filing Date
CN202011091427.9A Division CN112206223B (zh) 2013-12-20 2014-12-17 透皮释放活性物质的系统

Publications (1)

Publication Number Publication Date
CN105873634A true CN105873634A (zh) 2016-08-17

Family

ID=49880573

Family Applications (2)

Application Number Title Priority Date Filing Date
CN202011091427.9A Active CN112206223B (zh) 2013-12-20 2014-12-17 透皮释放活性物质的系统
CN201480070086.3A Pending CN105873634A (zh) 2013-12-20 2014-12-17 透皮释放活性物质的系统

Family Applications Before (1)

Application Number Title Priority Date Filing Date
CN202011091427.9A Active CN112206223B (zh) 2013-12-20 2014-12-17 透皮释放活性物质的系统

Country Status (13)

Country Link
US (2) US10485967B2 (enExample)
EP (2) EP2886153A1 (enExample)
JP (1) JP6560679B2 (enExample)
KR (1) KR20160102002A (enExample)
CN (2) CN112206223B (enExample)
AU (1) AU2014365899B2 (enExample)
BR (1) BR112016013278B1 (enExample)
CA (1) CA2934318C (enExample)
ES (1) ES2661836T3 (enExample)
HK (1) HK1223583A1 (enExample)
MX (1) MX2016008138A (enExample)
RU (1) RU2687090C1 (enExample)
WO (1) WO2015090583A1 (enExample)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107670022A (zh) * 2017-09-06 2018-02-09 华中农业大学 一种催产素透皮剂及其制备方法和应用
CN108159563A (zh) * 2016-12-07 2018-06-15 恩客斯（上海）商贸有限公司 电皮肤裹布
CN110694036A (zh) * 2019-08-21 2020-01-17 云南中医药大学 一种具有缓释功能的三伏贴及其制备方法
CN111417429A (zh) * 2017-10-12 2020-07-14 瑞士Spa系统有限公司 可持在手中的用于电辅助的皮肤治疗的装置、用于该装置的备件和用于该备件的泡罩
WO2020143633A1 (zh) * 2019-01-08 2020-07-16 上海肤泰科技有限公司 一种用于透皮离子电渗给药的皮肤贴膜

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018191317A1 (en) * 2017-04-10 2018-10-18 Battelle Memorial Institute Mixed ionic electronic conductors for improved charge transport in electrotherapeutic devices
CN111278503B (zh) * 2017-09-12 2023-12-05 Lts勒曼治疗系统股份公司 离子电渗微针装置
EP3863708B1 (en) * 2018-10-09 2024-09-11 Battelle Memorial Institute Mixed ionic conductors and corresponding devices, systems and methods of making
US11364225B2 (en) * 2019-08-21 2022-06-21 Bn Intellectual Properties, Inc. Pharmaceutical formulation for treating symptoms of migraine and cluster headaches, and method of using the same
CN115916215A (zh) * 2020-04-16 2023-04-04 长矛治疗股份有限公司 迷幻剂衍生物的经皮微剂量递送
CN115667217A (zh) 2020-05-19 2023-01-31 赛本爱尔兰有限公司 氘化的色胺衍生物和使用方法
US11312684B1 (en) 2021-02-10 2022-04-26 Eleusis Therapeutics Us, Inc. Pharmaceutically acceptable salts of psilocin and uses thereof
US20230026731A1 (en) * 2021-03-31 2023-01-26 Mycrodose Therapeutics Inc. Transdermal system, formulation, and method for the therapeutic administration of a psychedelic agent
WO2023168022A1 (en) 2022-03-04 2023-09-07 Reset Pharmaceuticals, Inc. Co-crystals or salts comprising psilocybin

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5645526A (en) * 1994-09-30 1997-07-08 Becton Dickinson And Company Apparatus and method for ensuring compatibility of a reusable iontophoretic controller with an iontophoretic patch
CN1224341A (zh) * 1996-07-02 1999-07-28 美国3M公司 医用粘性复合物和包装袋
US20020019652A1 (en) * 1999-07-08 2002-02-14 Cyclotec Advanced Medical Technologies Two part tens bandage
CN100551463C (zh) * 2003-03-31 2009-10-21 阿尔萨公司 具有带柔性导电元件的贮存器壳体的电迁移设备
US20100076387A1 (en) * 2008-09-23 2010-03-25 Pharmapatch Llc Twin Transdermal Drug Delivery Patch
CN101790373A (zh) * 2007-05-31 2010-07-28 费廷药业股份有限公司 烟草生物碱储库型经皮贴剂
CN102164632A (zh) * 2008-09-09 2011-08-24 透皮株式会社 对诸如透皮输送装置等装置进行供电和/或控制的系统、装置和方法
CN103228318A (zh) * 2010-11-23 2013-07-31 纽帕特公司 使用者激活的自包含共封装的离子透入给药系统

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US222276A (en) 1879-12-02 Improvement in combined galvanic and medicated pad
US486902A (en) 1892-11-29 Galvanic body-battery
JPS5514343Y2 (enExample) * 1975-11-22 1980-04-01
JPS5270787A (en) 1975-12-10 1977-06-13 Nippon Telegr & Teleph Corp <Ntt> Mechanical operation unit
ES2082973T3 (es) 1990-03-30 1996-04-01 Alza Corp Dispositivo para administracion iontoforetica de farmacos.
DE4014913C2 (de) 1990-05-10 1996-05-15 Lohmann Therapie Syst Lts Miniaturisiertes transdermales therapeutisches System für die Iontophorese
FI944321L (fi) * 1992-11-05 1994-11-16 Becton Dickinson Co Käyttäjäaktivoitu iontoforeettinen laite ja menetelmä sen käyttämiseksi
JP4154016B2 (ja) 1997-12-30 2008-09-24 久光製薬株式会社 イオントフォレーシス装置およびその組み立て方法
US7127285B2 (en) * 1999-03-12 2006-10-24 Transport Pharmaceuticals Inc. Systems and methods for electrokinetic delivery of a substance
US6553253B1 (en) * 1999-03-12 2003-04-22 Biophoretic Therapeutic Systems, Llc Method and system for electrokinetic delivery of a substance
DE10042412B4 (de) * 2000-08-30 2005-12-22 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches System zur Abgabe von Venlafaxin, und seine Verwendung
DE10159745A1 (de) * 2001-12-05 2003-07-03 Lohmann Therapie Syst Lts Transdermales Therapeutisches System mit verbessertem Langzeittragekomfort
US6745071B1 (en) 2003-02-21 2004-06-01 Birch Point Medical, Inc. Iontophoretic drug delivery system
MX2011002407A (es) * 2008-09-05 2011-07-28 Travanti Pharma Inc Envase para la administracion iontoforetica de un farmaco.
JP5755623B2 (ja) 2012-09-28 2015-07-29 株式会社 資生堂 シート電極

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5645526A (en) * 1994-09-30 1997-07-08 Becton Dickinson And Company Apparatus and method for ensuring compatibility of a reusable iontophoretic controller with an iontophoretic patch
CN1224341A (zh) * 1996-07-02 1999-07-28 美国3M公司 医用粘性复合物和包装袋
US20020019652A1 (en) * 1999-07-08 2002-02-14 Cyclotec Advanced Medical Technologies Two part tens bandage
CN100551463C (zh) * 2003-03-31 2009-10-21 阿尔萨公司 具有带柔性导电元件的贮存器壳体的电迁移设备
CN101790373A (zh) * 2007-05-31 2010-07-28 费廷药业股份有限公司 烟草生物碱储库型经皮贴剂
CN102164632A (zh) * 2008-09-09 2011-08-24 透皮株式会社 对诸如透皮输送装置等装置进行供电和/或控制的系统、装置和方法
US20100076387A1 (en) * 2008-09-23 2010-03-25 Pharmapatch Llc Twin Transdermal Drug Delivery Patch
CN103228318A (zh) * 2010-11-23 2013-07-31 纽帕特公司 使用者激活的自包含共封装的离子透入给药系统

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108159563A (zh) * 2016-12-07 2018-06-15 恩客斯（上海）商贸有限公司 电皮肤裹布
CN107670022A (zh) * 2017-09-06 2018-02-09 华中农业大学 一种催产素透皮剂及其制备方法和应用
CN107670022B (zh) * 2017-09-06 2020-07-10 华中农业大学 一种催产素透皮剂及其制备方法和应用
CN111417429A (zh) * 2017-10-12 2020-07-14 瑞士Spa系统有限公司 可持在手中的用于电辅助的皮肤治疗的装置、用于该装置的备件和用于该备件的泡罩
CN111417429B (zh) * 2017-10-12 2024-04-09 瑞士Spa系统有限公司 可持在手中的用于电辅助的皮肤治疗的装置、用于该装置的备件和用于该备件的泡罩
WO2020143633A1 (zh) * 2019-01-08 2020-07-16 上海肤泰科技有限公司 一种用于透皮离子电渗给药的皮肤贴膜
CN110694036A (zh) * 2019-08-21 2020-01-17 云南中医药大学 一种具有缓释功能的三伏贴及其制备方法

Also Published As

Publication number Publication date
CN112206223B (zh) 2024-07-02
CA2934318A1 (en) 2015-06-25
HK1223583A1 (zh) 2017-08-04
EP3082942A1 (de) 2016-10-26
EP3082942B1 (de) 2018-02-28
ES2661836T3 (es) 2018-04-04
JP2016540818A (ja) 2016-12-28
BR112016013278A2 (enExample) 2017-08-08
MX2016008138A (es) 2016-09-16
US20160303361A1 (en) 2016-10-20
WO2015090583A1 (de) 2015-06-25
RU2687090C1 (ru) 2019-05-07
CN112206223A (zh) 2021-01-12
EP2886153A1 (de) 2015-06-24
US11439807B2 (en) 2022-09-13
KR20160102002A (ko) 2016-08-26
RU2016129497A (ru) 2018-01-26
AU2014365899A1 (en) 2016-07-07
US10485967B2 (en) 2019-11-26
BR112016013278B1 (pt) 2021-09-08
CA2934318C (en) 2022-02-22
JP6560679B2 (ja) 2019-08-14
AU2014365899B2 (en) 2019-03-14
US20200046963A1 (en) 2020-02-13

Similar Documents

Publication Publication Date Title
US11439807B2 (en) System for the transdermal delivery of active ingredient
ES2245649T3 (es) Un sistema de entrega de farmaco dual adhesivo transdermico.
JP4721902B2 (ja) 用時活性化型イオントフォレーシスデバイス
KR101656537B1 (ko) 양이온성 활성제의 경피 전달용 조성물
JPH08509200A (ja) 薬含有超乳濁液の適用装置
AU1684599A (en) Iontophoresis device and drug unit
HK1201763A1 (en) Polyamine enhanced formulations for triptan compound iontophoresis
KR20140022783A (ko) 이온 도입 치료법에 사용되는 전극 패드
DE102008013701A1 (de) Transdermales Therapeutisches System mit stabilisierter Membran
US20040191301A1 (en) Transdermal device having a phase change material
JP2011523650A (ja) ケトチフェン経皮薬物送達システム及び眼科疾患の治療方法
IL211504A (en) Design and mini-delivery of a sacrificial electrode suitable for extended iontophoresis application periods
US20070020321A1 (en) Method for enhancing attenuation characteristic of absorbent materials useful with dermal and transdermal substance delivery systems
CA2664998A1 (en) Pulsatile delivery of gonadotropin-releasing hormone from a pre-loaded integrated electrotransport patch
US20140288481A1 (en) Transdermal patch with non-water soluble adhesive and anesthetic
JP3119488B2 (ja) 水溶性ステロイド用イオントフォレーシスデバイス
Sowmya et al. Transdermal therapeutic systems—An overview
JPH08317996A (ja) イオントフォレシス用インターフェイス
HK40025187A (en) Microneedle array having an active ingredient in the form of salts
AU2010202032A1 (en) A dual adhesive transdermal drug delivery system

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1223583

Country of ref document: HK

RJ01 Rejection of invention patent application after publication

Application publication date: 20160817

RJ01 Rejection of invention patent application after publication
REG Reference to a national code

Ref country code: HK

Ref legal event code: WD

Ref document number: 1223583

Country of ref document: HK